[6-hydroxy-1,3-benzoxathiol-2-one, an antipsoriatic with antibacterial and antimycotic properties].
D000818:Animals; D000873:Anthracenes / Q000494:pharmacology*; D000891:Anti-Infective Agents, Local / Q000494:pharmacology* / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000494:pharmacology*; D001230:Aspergillus / Q000187:drug effects; D001419:Bacteria / Q000187:drug effects*; D002175:Candida / Q000187:drug effects; D003864:Depression, Chemical; D003879:Dermatologic Agents; D004361:Drug Tolerance; D004821:Epidermophyton / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D005658:Fungi / Q000187:drug effects*; D006168:Guinea Pigs; D008297:Male; D008864:Microsporum / Q000187:drug effects; D003904:Mitosporic Fungi / Q000187:drug effects; D009089:Mucor / Q000187:drug effects; D009824:Ointments; D010407:Penicillium / Q000187:drug effects; D010592:Pharmaceutic Aids; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011565:Psoriasis / Q000188:drug therapy; D012440:Saccharomyces / Q000187:drug effects; D012867:Skin / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D014005:Tinea / Q000188:drug therapy*; D014249:Trichophyton / Q000187:drug effects; D014945:Wound Healing / Q000187:drug effects
D000873:Anthracenes; D000891:Anti-Infective Agents, Local; D000935:Antifungal Agents; D003879:Dermatologic Agents; D009824:Ointments; D010592:Pharmaceutic Aids
6-Hydroxy-1,3-benzoxathiol-2-on, ein Antipsoriaticum mit antibakteriellen und antimykotischen Eigenschaften.